| Literature DB >> 26091978 |
Lizhou Liu1, Margot Skinner2, Suzanne M McDonough3, Priya Kannan4, George David Baxter5.
Abstract
BACKGROUND: In order to facilitate the completeness and transparency of reporting on randomized controlled trials undertaken using acupuncture interventions, a consensus group of international experts developed the Standards for Reporting Interventions in Controlled Trials of Acupuncture (STRICTA) in 2002. This reporting guideline was updated in 2010, and was applicable to a broader range of acupuncture research, including uncontrolled trials and case reports. Subsequent evaluations have noted limitations on the impact of STRICTA in the reporting quality of acupuncture trials, and the description of acupuncture details remains poor. Thus improvement in the efficacy of the STRICTA guidelines is called for. DISCUSSION: We explored the STRICTA guidelines from four aspects, including the development procedure, validity assessment, endorsement and adherence, and citation situation. Based upon these findings, we provided five potential suggestions for further development of STRICTA.Entities:
Mesh:
Year: 2015 PMID: 26091978 PMCID: PMC4474462 DOI: 10.1186/s12906-015-0714-4
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Validity assessment of the STRICTA 2010 on reporting guidelines development process※
| Step | Item No. | Item | Satisfaction of STRICTA 2010 |
|---|---|---|---|
| Initial steps | 1 | Identify the need for a guideline | Yes |
| 2 | Review the literature | Yes | |
| 3 | Obtain funding for the guideline initiative | Yes | |
| Pre-meeting activities | 4 | Identify participants | Yes |
| 5 | Conduct a Delphi exercise | No | |
| 6 | Generate a list of items for consideration at the face-to-face meeting | No | |
| 7 | Prepare for the face-to-face meeting | No | |
| Face-to-face consensus meeting itself | 8 | Present and discuss results of pre-meeting activities and relevant evidence | No |
| Post-meeting activities | 9 | Develop the guidance statement | Yes |
| 10 | Develop an explanatory document (E&E) | Yes | |
| 11 | Develop a publication strategy | Yes | |
| Post-publication activities | 12 | Seek and deal with feedback and criticism | Yes |
| 13 | Encourage guideline endorsement | Yes | |
| 14 | Support adherence to the guideline | No | |
| 15 | Evaluate the impact of the reporting guidance | No | |
| 16 | Develop Web site | Yes | |
| 17 | Translate guideline | Yes | |
| 18 | Update guideline | No |
※Structured according to the EQUATOR Guidance for Developers of Health Research Reporting Guidelines [21]
E&E: explanation and elaboration
Validity assessment of the STRICTA 2010 on content integrity*
| Item No. | Item | Satisfaction of STRICTA 2010 |
|---|---|---|
| 1 | Brief name | Yes |
| Provide the name or a phrase that describes the intervention | ||
| 2 | Why | Yes |
| Describe any rationale, theory, or goal of the elements essential to the intervention | ||
| 3 | What (materials) | Yes |
| Describe any physical or informational materials used in the intervention, including those provided to participants or used in intervention delivery or in training of intervention providers. Provide information on where the materials can be accessed (such as online appendix, URL) | ||
| 4 | What (procedures) | Yes |
| Describe each of the procedures, activities, and/or processes used in the intervention, including any enabling or support activities | ||
| 5 | Who provided | Yes |
| For each category of intervention provider (e.g. psychologist, nursing assistant), describe their expertise, background and any specific training given | ||
| 6 | How | No |
| Describe the modes of delivery (e.g. face-to-face or by some other mechanism, such as internet or telephone) of the intervention and whether it was provided individually or in a group | ||
| 7 | Where | Yes |
| Describe the type(s) of location(s) where the intervention occurred, including any necessary infrastructure or relevant features | ||
| 8 | When and how much | Yes |
| Describe the number of times the intervention was delivered and over what period of time including the number of sessions, their schedule, and their duration, intensity or dose | ||
| 9 | Tailoring | Yes |
| If the intervention was planned to be personalised, titrated or adapted, then describe what, why, when, and how | ||
| 10∮ | Modifications | No |
| If the intervention was modified during the course of the study, describe the changes (what, why, when, and how) | ||
| 11 | How well (planned) | No |
| If intervention adherence or fidelity was assessed, describe how and by whom, and if any strategies were used to maintain or improve fidelity, describe them | ||
| 12∮ | How well (actual) | No |
| If intervention adherence or fidelity was assessed, describe the extent to which the intervention was delivered as planned |
*Structured according to the Template for Intervention Description and Replication (TIDieR) [23]
∮Not applicable to a protocol
“Instructions to authors” of journals that endorsed STRICTA
| Journal | Mention of STRICTA | Specific requirement of STRICTA (quote) | STRICTA website link | Appropriate reference | Mention of EQUATOR | Other reporting guidelines |
|---|---|---|---|---|---|---|
| Acupuncture in Medicine | Yes |
| No, but hyperlink to the STRICTA checklist | Yes | Yes | CONSORT, PRISMA, MOOSE, STROBE, STARD, SQUIRE |
| Australian Journal of Acupuncture and Chinese Medicine | Yes |
| Yes, but inaccessible URL | NR | No | CONSORT, QUOROM |
| Deutsche Zeitschrift für Akupunktur/German Journal of Acupuncture and Related Techniques | Yes |
| Yes | NR | No | No |
| Journal of Alternative and Complementary Medicine | Yes |
| Yes | No (Inappropriate Title) | No | CONSORT |
| Journal of Integrative Medicine | No | NR | No | NR | No | CONSORT, PRISMA |
| Journal of Evidence-Based Medicine | Yes |
| Yes | Yes | No | CONSORT, PRISMA |
| Korean Journal of Acupuncture | No | NR | No | NR | No | No |
| Medical Acupuncture | Yes |
| Yes | NR | No | No |
| PLoS Medicine | No | NR | No | NR | Yes | CONSORT, PRISMA, STARD, STROBE, MIAME, MIBBI, ARRIVE |
NA: not reported
STRICTA: Standards for Reporting Interventions in Clinical Trials of Acupuncture; EQUATOR: Enhancing the Quality and Transparency of Health Research; CONSORT: Consolidated Standards of Reporting Trials; PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses; MOOSE: Meta-analysis of Observational Studies in Epidemiology; STROBE: Strengthening the Reporting of Observational Studies in Epidemiology; STARD: Standards for Reporting of Diagnostic Accuracy; SQUIRE: Standards for Quality Improvement Reporting Excellence; QUOROM: Quality of Reporting of Meta-analyses; MIAME: Minimum Information About a Microarray Experiment; MIBBI: Minimum Information for Biological and Biomedical Investigations; ARRIVE: Animal Research: Reporting In Vivo Experiments
Fig. 1Citation of STRICTA 2002 in all studies
Fig. 2Citation of STRICTA 2002 in RCTs
Fig. 3Citation of STRICTA 2010 in all studies
Fig. 4Citation of STRICTA 2010 in RCTs
Fig. 5Publication location of articles citing STRICTA 2002
Fig. 6Publication location of articles citing STRICTA 2010